Target
Protein mono-ADP-ribosyltransferase PARP14 [1611-1801]
Ligand
BDBM434151
Substrate
n/a
Meas. Tech.
Enzymatic Inhibition Assay
IC50
<1000±n/a nM
Citation
 Schenkel, LBVasbinder, MMKuntz, KWSwinger, KK Quinazolinones as PARP14 inhibitors US Patent  US10562891 Publication Date 2/18/2020 
Target
Name:
Protein mono-ADP-ribosyltransferase PARP14 [1611-1801]
Synonyms:
BAL2 | KIAA1268 | PAR14_HUMAN | PARP14 | Protein mono-ADP-ribosyltransferase PARP14 (aa 1611-1801)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
21749.94
Organism:
Homo sapiens (Human)
Description:
aa 1611-1801
Residue:
190
Sequence:
DMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFR
  
Inhibitor
Name:
BDBM434151
Synonyms:
US10562891, Example 73 | US11008308, Example 73
Type:
Small organic molecule
Emp. Form.:
C18H25N3OS
Mol. Mass.:
331.476
SMILES:
CNC[C@H]1CC[C@@H](CC1)SCc1nc2c(C)cccc2c(=O)[nH]1 |r,wU:6.9,wD:3.2,(8,-3.47,;6.67,-2.69,;5.33,-3.47,;4,-2.69,;4,-1.15,;2.67,-.38,;1.33,-1.15,;1.33,-2.69,;2.67,-3.47,;,-.38,;-1.33,-1.15,;-2.67,-.38,;-4,-1.15,;-5.33,-.38,;-6.67,-1.15,;-6.67,-2.69,;-8,-.38,;-8,1.15,;-6.67,1.93,;-5.33,1.15,;-4,1.93,;-4,3.47,;-2.67,1.15,)|
Structure:
Search PDB for entries with ligand similarity: